Who is the CEO of Conduit Pharmaceuticals Inc.?

The CEO of Conduit Pharmaceuticals Inc. is Andrew Regan.

What industry does Conduit Pharmaceuticals Inc. belong to?

Conduit Pharmaceuticals Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Conduit Pharmaceuticals Inc. headquartered?

Conduit Pharmaceuticals Inc. is headquartered at 89 Nexus Way, Grand Cayman, KY1-9009, KY.

How many employees does Conduit Pharmaceuticals Inc. have?

Conduit Pharmaceuticals Inc. has approximately 6 full-time employees.

Conduit Pharmaceuticals Inc.

CDTTW•NASDAQ

Healthcare

Biotechnology

$0.01

$0.002(16.28%)

Conduit Pharmaceuticals Inc. (CDTTW) Company Profile & Overview

Explore Conduit Pharmaceuticals Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Conduit Pharmaceuticals Inc. (CDTTW) Company Profile & Overview

Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.

SectorHealthcare

IndustryBiotechnology

CEOAndrew Regan

Contact Information

https://www.conduitpharma.com

89 Nexus Way, Grand Cayman, KY1-9009

Company Facts

6 Employees

CountryKY

Actively Trading

Frequently Asked Questions

;